ANIP - ANI Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ANIP is currently covered by 3 analysts with an average price target of $119.17. This is a potential upside of $22.35 (52.74%) from yesterday's end of day stock price of $78.02.

ANI Pharmaceuticals's activity chart (see below) currently has 39 price targets and 38 ratings on display. The stock rating distribution of ANIP is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 85.7% with an average time for these price targets to be met of 468.86 days.

Highest price target for ANIP is $124, Lowest price target is $115, average price target is $119.17.

Most recent stock forecast was given by VAMIL DIVAN from GUGGENHEIM on 10-Aug-2026. First documented stock forecast 15-Dec-2014.

Currently out of the existing stock ratings of ANIP, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Mar-2023

$119

$42.46 (55.47%)

$124

Buy Since 12-Mar-2025

$115

$30.5 (36.09%)

$85

Buy Since 06-Nov-2019

$121

$36.5 (43.20%)

$93

Buy Since 07-Sep-2022

$94

$9.5 (11.24%)

$94

Buy Since 03-Nov-2021

$60

$-18.36 (-23.43%)

$52

Show more analysts

Please expand the browser size to see the chart

What is ANIP (ANI Pharmaceuticals) average time for price targets to be met?

On average it took 468.86 days on average for the stock forecasts to be realized with a an average price target met ratio 85.7

Which analyst has the current highest performing score on ANIP (ANI Pharmaceuticals) with a proven track record?

OREN LIVNAT

Which analyst has the most public recommendations on ANIP (ANI Pharmaceuticals)?

Oren Livnat works at HC WAINWRIGHT and has 16 price targets and 12 ratings on ANIP

Which analyst is the currently most bullish on ANIP (ANI Pharmaceuticals)?

Brandon Folkes with highest potential upside - $44.46

Which analyst is the currently most reserved on ANIP (ANI Pharmaceuticals)?

Elliot Wilbur with lowest potential downside - -$29.36

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?